EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Stephan Windecker


Stephan Windecker, Switzerland, President of the EAPCI, is the Chairman of the Department of Cardiology at the University Hospital in Bern. With a TAVI programme that started in 2008, the centre currently performs over 300 procedures a year. As the Chair-Elect of the ESC Committee for Practice Guidelines, evidence-based medicine is very important to Windecker.
I am looking forward to the Great Debate and your participation in order to illustrate that TAVI is not only a less-invasive therapy in comparison to surgical aortic valve replacement, but also  superior in all respects including all-cause of  mortality.